US FDA drops controversial recall report idea for device enhancements
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration does not expect medtech companies to submit "corrections and removals" reports for medical device enhancements that do not qualify as recalls, according to a newly finalized version of a draft guidance that came under fire by industry last year1,2.